Related Experiment Video
Updated: Aug 1, 2025

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
The anticancer peptide LL-III binds with nanomolar affinity to human telomeric and cMyc G-quadruplexes
Marco Campanile1, Rosario Oliva1, Pompea Del Vecchio1
1Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126, Naples, Italy. luigi.petraccone@unina.it.
Abstract:
LL-III is a natural anticancer peptide able to cross the membrane of cancer cells and to localize in the nucleolus, but its intracellular target is unknown. Here, we show that LL-III is able to bind with nM affinity to specific G-quadruplex structures known to be relevant anticancer targets.
More Related Videos
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Replicative Cell Senescence
Abnormal Proliferation